Gene therapy could turn off the immune response that causes allergic reactions, according to a new study.
Application of gene therapy for achieving longevity is full of medical and ethical conundrums.
Researchers from Ben-Gurion University of the Negev (BGU) have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).
Children and young adults with X-linked severe combined immunodeficiency (SCID-X1) are now safe to undergo gene therapy, according to a recent study.
Cystic fibrosis (CF)--a genetic disorder that results in buildups of mucus in the body--is caused by a mutation in the CFTR gene.
Scientists have found the genetic underpinnings of achromatopsia in dogs, which is a rare, inherited vision disorder that affects the eye's cone cells, which could help humans in the future.
A new gene therapy for cystic fibrosis could be huge in terms of improving lung function.
A new study has shown that gene therapy can help to temporarily improve eyesight in patients who are suffering from Leber congenital amaurosis (LCA), an inherited disorder that results in vision loss beginning in childhood.
Toby Stroh was in his 20s when his doctor told him he would go blind in his 50s, and his years of playing tennis and being able to drive or work could be gone long before that.